A citation-based method for searching scientific literature

Angela R Bradbury, Linda J Patrick-Miller, Brian L Egleston, Michael J Hall, Susan M Domchek, Mary B Daly, Pamela Ganschow, Generosa Grana, Olufunmilayo I Olopade, Dominique Fetzer, Amanda Brandt, Rachelle Chambers, Dana F Clark, Andrea Forman, Rikki Gaber, Cassandra Gulden, Janice Horte, Jessica M Long, Terra Lucas, Shreshtha Madaan, Kristin Mattie, Danielle McKenna, Susan Montgomery, Sarah Nielsen, Jacquelyn Powers, Kim Rainey, Christina Rybak, Michelle Savage, Christina Seelaus, Jessica Stoll, Jill E Stopfer, Xinxin Shirley Yao. J Natl Cancer Inst 2018
Times Cited: 20







List of co-cited articles
79 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Randomized Noninferiority Trial of Telephone Delivery of BRCA1/2 Genetic Counseling Compared With In-Person Counseling: 1-Year Follow-Up.
Anita Y Kinney, Laurie E Steffen, Barbara H Brumbach, Wendy Kohlmann, Ruofei Du, Ji-Hyun Lee, Amanda Gammon, Karin Butler, Saundra S Buys, Antoinette M Stroup,[...]. J Clin Oncol 2016
61
40

Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.
Marc D Schwartz, Heiddis B Valdimarsdottir, Beth N Peshkin, Jeanne Mandelblatt, Rachel Nusbaum, An-Tsun Huang, Yaojen Chang, Kristi Graves, Claudine Isaacs, Marie Wood,[...]. J Clin Oncol 2014
148
35

Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial.
Anita Y Kinney, Karin M Butler, Marc D Schwartz, Jeanne S Mandelblatt, Kenneth M Boucher, Lisa M Pappas, Amanda Gammon, Wendy Kohlmann, Sandra L Edwards, Antoinette M Stroup,[...]. J Natl Cancer Inst 2014
73
35

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.
Mark E Robson, Angela R Bradbury, Banu Arun, Susan M Domchek, James M Ford, Heather L Hampel, Stephen M Lipkin, Sapna Syngal, Dana S Wollins, Noralane M Lindor. J Clin Oncol 2015
296
35

Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
30

Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients.
Heidi S Lumish, Hallie Steinfeld, Carrie Koval, Donna Russo, Elana Levinson, Julia Wynn, James Duong, Wendy K Chung. J Genet Couns 2017
61
30

Utilizing Remote Real-Time Videoconferencing to Expand Access to Cancer Genetic Services in Community Practices: A Multicenter Feasibility Study.
Angela Bradbury, Linda Patrick-Miller, Diana Harris, Evelyn Stevens, Brian Egleston, Kyle Smith, Rebecca Mueller, Amanda Brandt, Jill Stopfer, Shea Rauch,[...]. J Med Internet Res 2016
40
25

Cancer genetics knowledge and beliefs and receipt of results in Ashkenazi Jewish individuals receiving counseling for BRCA1/2 mutations.
Kimberly Kelly, Howard Leventhal, Monica Marvin, Deborah Toppmeyer, Jill Baran, Marvin Schwalb. Cancer Control 2004
28
25

Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibility.
Angela R Bradbury, Linda Patrick-Miller, Jessica Long, Jacquelyn Powers, Jill Stopfer, Andrea Forman, Christina Rybak, Kristin Mattie, Amanda Brandt, Rachelle Chambers,[...]. Genet Med 2015
52
25

The hospital anxiety and depression scale.
A S Zigmond, R P Snaith. Acta Psychiatr Scand 1983
25

A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire.
David Cella, Chanita Hughes, Amy Peterman, Chih-Hung Chang, Beth N Peshkin, Marc D Schwartz, Lari Wenzel, Amy Lemke, Alfred C Marcus, Caryn Lerman. Health Psychol 2002
166
25

Development of a communication protocol for telephone disclosure of genetic test results for cancer predisposition.
Linda J Patrick-Miller, Brian L Egleston, Dominique Fetzer, Andrea Forman, Lisa Bealin, Christina Rybak, Candace Peterson, Melanie Corbman, Julio Albarracin, Evelyn Stevens,[...]. JMIR Res Protoc 2014
17
29

Patient feedback and early outcome data with a novel tiered-binned model for multiplex breast cancer susceptibility testing.
Angela R Bradbury, Linda J Patrick-Miller, Brian L Egleston, Laura DiGiovanni, Jamie Brower, Diana Harris, Evelyn M Stevens, Kara N Maxwell, Abha Kulkarni, Tyler Chavez,[...]. Genet Med 2016
40
25

Telegenetics: a systematic review of telemedicine in genetics services.
Jennifer S Hilgart, Julie A Hayward, Bernadette Coles, Rachel Iredale. Genet Med 2012
85
25

Cancer genetic counseling: communication and counselees' post-visit satisfaction, cognitions, anxiety, and needs fulfillment.
Arwen H Pieterse, Alexandra M van Dulmen, Frits A Beemer, Jozien M Bensing, Margreet G E M Ausems. J Genet Couns 2007
46
20

Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling.
Morgan Butrick, Scott Kelly, Beth N Peshkin, George Luta, Rachel Nusbaum, Gillian W Hooker, Kristi Graves, Lisa Feeley, Claudine Isaacs, Heiddis B Valdimarsdottir,[...]. Genet Med 2015
58
20

Examination of the Patient-Focused Impact of Cancer Telegenetics Among a Rural Population: Comparison with Traditional In-Person Services.
Nan M Solomons, Amanda E Lamb, Frances L Lucas, Eileen F McDonald, Susan Miesfeldt. Telemed J E Health 2018
20
20

Randomized Trial of Telegenetics vs. In-Person Cancer Genetic Counseling: Cost, Patient Satisfaction and Attendance.
Adam H Buchanan, Santanu K Datta, Celette Sugg Skinner, Gail P Hollowell, Henry F Beresford, Thomas Freeland, Benjamin Rogers, John Boling, P Kelly Marcom, Martha B Adams. J Genet Couns 2015
78
20


Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer.
Allison W Kurian, Kevin C Ward, Ann S Hamilton, Dennis M Deapen, Paul Abrahamse, Irina Bondarenko, Yun Li, Sarah T Hawley, Monica Morrow, Reshma Jagsi,[...]. JAMA Oncol 2018
67
20

Preferences for in-person disclosure: Patients declining telephone disclosure characteristics and outcomes in the multicenter Communication Of GENetic Test Results by Telephone study.
Nina Beri, Linda J Patrick-Miller, Brian L Egleston, Michael J Hall, Susan M Domchek, Mary B Daly, Pamela Ganschow, Generosa Grana, Olufunmilayo I Olopade, Dominique Fetzer,[...]. Clin Genet 2019
8
50

Use and Patient-Reported Outcomes of Clinical Multigene Panel Testing for Cancer Susceptibility in the Multicenter Communication of Genetic Test Results by Telephone Study.
Michael J Hall, Linda J Patrick-Miller, Brian L Egleston, Susan M Domchek, Mary B Daly, Pamela Ganschow, Generosa Grana, Olufunmilayo I Olopade, Dominique Fetzer, Amanda Brandt,[...]. JCO Precis Oncol 2018
8
50

Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians.
Cecelia A Bellcross, Katherine Kolor, Katrina A B Goddard, Ralph J Coates, Michele Reyes, Muin J Khoury. Am J Prev Med 2011
111
15

Psychological Distress, Anxiety, and Depression of Cancer-Affected BRCA1/2 Mutation Carriers: a Systematic Review.
Johanna Ringwald, Christina Wochnowski, Kristin Bosse, Katrin Elisabeth Giel, Norbert Schäffeler, Stephan Zipfel, Martin Teufel. J Genet Couns 2016
39
15

Inherited Mutations in Women With Ovarian Carcinoma.
Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger,[...]. JAMA Oncol 2016
335
15

Randomized comparison of phone versus in-person BRCA1/2 predisposition genetic test result disclosure counseling.
Jean Jenkins, Kathleen A Calzone, Eileen Dimond, David J Liewehr, Seth M Steinberg, Oxana Jourkiv, Pam Klein, Peter W Soballe, Sheila A Prindiville, Ilan R Kirsch. Genet Med 2007
53
15

Implementation and outcomes of telephone disclosure of clinical BRCA1/2 test results.
Linda Patrick-Miller, Brian L Egleston, Mary Daly, Evelyn Stevens, Dominique Fetzer, Andrea Forman, Lisa Bealin, Christina Rybak, Candace Peterson, Melanie Corbman,[...]. Patient Educ Couns 2013
16
18

Multigene Panel Testing in Oncology Practice: How Should We Respond?
Allison W Kurian, James M Ford. JAMA Oncol 2015
43
15

Genetic counselor opinions of, and experiences with telephone communication of BRCA1/2 test results.
A R Bradbury, L Patrick-Miller, D Fetzer, B Egleston, S A Cummings, A Forman, L Bealin, C Peterson, M Corbman, J O'Connell,[...]. Clin Genet 2011
31
15

Next-Generation Service Delivery: A Scoping Review of Patient Outcomes Associated with Alternative Models of Genetic Counseling and Genetic Testing for Hereditary Cancer.
Jeanna M McCuaig, Susan Randall Armel, Melanie Care, Alexandra Volenik, Raymond H Kim, Kelly A Metcalfe. Cancers (Basel) 2018
29
15

Alternate Service Delivery Models in Cancer Genetic Counseling: A Mini-Review.
Adam Hudson Buchanan, Alanna Kulchak Rahm, Janet L Williams. Front Oncol 2016
55
15

Genetic Counselors' Experiences and Interest in Telegenetics and Remote Counseling.
Heather A Zierhut, Ian M MacFarlane, Zahra Ahmed, Jill Davies. J Genet Couns 2018
34
15

Genetic Testing in a Population-Based Sample of Breast and Ovarian Cancer Survivors from the REACH Randomized Trial: Cost Barriers and Moderators of Counseling Mode.
Laurie E Steffen, Ruofei Du, Amanda Gammon, Jeanne S Mandelblatt, Wendy K Kohlmann, Ji-Hyun Lee, Saundra S Buys, Antoinette M Stroup, Rebecca A Campo, Kristina G Flores,[...]. Cancer Epidemiol Biomarkers Prev 2017
10
30

Multiplex genetic testing for cancer susceptibility: out on the high wire without a net?
Susan M Domchek, Angela Bradbury, Judy E Garber, Kenneth Offit, Mark E Robson. J Clin Oncol 2013
156
15


Clinical models of telehealth in genetics: A regional telegenetics landscape.
Alissa B Terry, Amanda Wylie, Melissa Raspa, Beth Vogel, Kunal Sanghavi, Luba Djurdjinovic, Michele Caggana, Joann Bodurtha. J Genet Couns 2019
19
15

Genetic Counseling Service Delivery Models in the United States: Assessment of changes in use from 2010 to 2017.
Samantha E Greenberg, Emily Boothe, Christine L Delaney, Ryan Noss, Stephanie A Cohen. J Genet Couns 2020
10
30

Breast-cancer risk in families with mutations in PALB2.
Antonis C Antoniou, Silvia Casadei, Tuomas Heikkinen, Daniel Barrowdale, Katri Pylkäs, Jonathan Roberts, Andrew Lee, Deepak Subramanian, Kim De Leeneer, Florentia Fostira,[...]. N Engl J Med 2014
472
10

Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award.
Mary-Claire King, Ephrat Levy-Lahad, Amnon Lahad. JAMA 2014
172
10

Gene-panel sequencing and the prediction of breast-cancer risk.
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015
488
10

Counselling framework for moderate-penetrance cancer-susceptibility mutations.
Nadine Tung, Susan M Domchek, Zsofia Stadler, Katherine L Nathanson, Fergus Couch, Judy E Garber, Kenneth Offit, Mark E Robson. Nat Rev Clin Oncol 2016
156
10

Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment.
Allison W Kurian, Emily E Hare, Meredith A Mills, Kerry E Kingham, Lisa McPherson, Alice S Whittemore, Valerie McGuire, Uri Ladabaum, Yuya Kobayashi, Stephen E Lincoln,[...]. J Clin Oncol 2014
303
10

A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian Cancer.
Anthony Eccleston, Anthony Bentley, Matthew Dyer, Ann Strydom, Wim Vereecken, Angela George, Nazneen Rahman. Value Health 2017
30
10

Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers.
Marjanka K Schmidt, Frans Hogervorst, Richard van Hien, Sten Cornelissen, Annegien Broeks, Muriel A Adank, Hanne Meijers, Quinten Waisfisz, Antoinette Hollestelle, Mieke Schutte,[...]. J Clin Oncol 2016
74
10

Hereditary predisposition to ovarian cancer, looking beyond BRCA1/BRCA2.
Lindsey E Minion, Jill S Dolinsky, Dana M Chase, Charles L Dunlop, Elizabeth C Chao, Bradley J Monk. Gynecol Oncol 2015
64
10

Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.
Nadine Tung, Chiara Battelli, Brian Allen, Rajesh Kaldate, Satish Bhatnagar, Karla Bowles, Kirsten Timms, Judy E Garber, Christina Herold, Leif Ellisen,[...]. Cancer 2015
252
10

Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach.
Goli Samimi, Marcus Q Bernardini, Lawrence C Brody, Charlisse F Caga-Anan, Ian G Campbell, Georgia Chenevix-Trench, Fergus J Couch, Michael Dean, Joanne A de Hullu, Susan M Domchek,[...]. J Clin Oncol 2017
33
10

Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.
Matthew B Yurgelun, Matthew H Kulke, Charles S Fuchs, Brian A Allen, Hajime Uno, Jason L Hornick, Chinedu I Ukaegbu, Lauren K Brais, Philip G McNamara, Robert J Mayer,[...]. J Clin Oncol 2017
165
10

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.
Mary B Daly, Robert Pilarski, Michael Berry, Saundra S Buys, Meagan Farmer, Susan Friedman, Judy E Garber, Noah D Kauff, Seema Khan, Catherine Klein,[...]. J Natl Compr Canc Netw 2017
287
10

Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer.
Nadine Tung, Nancy U Lin, John Kidd, Brian A Allen, Nanda Singh, Richard J Wenstrup, Anne-Renee Hartman, Eric P Winer, Judy E Garber. J Clin Oncol 2016
240
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.